CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 46  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0514
LYS 10.0250
GLU 20.0268
LEU 30.0318
ARG 40.0405
CYS 50.0076
GLN 60.0119
CYS 70.0067
ILE 80.0085
LYS 90.0113
THR 100.0082
TYR 110.0084
SER 120.0105
LYS 130.0144
PRO 140.0128
PHE 150.0164
HIS 160.0237
PRO 170.0282
LYS 180.0405
PHE 190.0262
ILE 200.0237
LYS 210.0318
GLU 220.0196
LEU 230.0049
ARG 240.0104
VAL 250.0213
ILE 260.0213
GLU 270.0181
SER 280.0106
GLY 290.0140
PRO 300.0311
HIS 310.0360
CYS 320.0238
ALA 330.0514
ASN 340.0125
THR 350.0181
GLU 360.0134
ILE 370.0142
ILE 380.0057
VAL 390.0132
LYS 400.0218
LEU 410.0178
SER 420.0226
ASP 430.0385
GLY 440.0114
ARG 450.0236
GLU 460.0242
LEU 470.0189
CYS 480.0064
LEU 490.0107
ASP 500.0311
PRO 510.0364
LYS 520.0471
GLU 530.0305
ASN 540.0263
TRP 550.0236
VAL 560.0200
GLN 570.0188
ARG 580.0203
VAL 590.0120
VAL 600.0136
GLU 610.0213
LYS 620.0203
PHE 630.0184
LEU 640.0087
LYS 650.0141
ARG 660.0215
ALA 670.0333
GLU 680.0263
ASN 690.0418

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.